0001949846-23-000080.txt : 20230515 0001949846-23-000080.hdr.sgml : 20230515 20230515164251 ACCESSION NUMBER: 0001949846-23-000080 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23923500 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SOUTHWELL DAVID P CENTRAL INDEX KEY: 0001251553 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INOTEK PHARMACEUTICALS CORPORATION STREET 2: 91 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 144 1 primary_doc.xml 144 0001251553 XXXXXXXX LIVE 0001783328 TScan Therapeutics, Inc. 001-40603 830 WINTER STREET WALTHAM MA 02451 857-399-9500 SOUTHWELL DAVID P Director Common Charles Schwab Company

3000 Schwab Way Westlake TX 76262

85911 346221.00 19480729 05/15/2023 Nasdaq Common 09/08/2021 Open Market Open Market N 12237 09/08/2021 Cash Common 03/02/2022 Exercised Stock Options Issuer N 48670 03/04/2022 Compensation Common 05/18/2022 Open Market Open Market N 25004 05/18/2022 Cash Y 05/15/2023 David Peabody Southwell